Abstract
ABSTRACT: The frequency of nonsurgical cosmetic procedures, specifically the injection of neuromuscular modulators produced by Clostridium botulinum type A exotoxin, frequently referred to as BoNTA, such as Botox Cosmetic (Allergan), Dysport (Medicis), and Xeomin (Merz), is increasingly common in the war on aging. Although the overall number of cosmetic surgical procedures has decreased, in the past decade, less-invasive injectable treatments have gained popularity. BoNTA agents are the most popular option for reducing or eliminating facial rhytids by causing dynamic muscle relaxation through chemodenervation of facial striated muscles. This article will provide an overview of indications, efficacy, risks, and product choices.